期刊文献+

干扰素-γ对宫颈癌细胞免疫分子表达的影响 被引量:2

Effect of interferon-γon expression of immune molecules on the cervical tumor cell
下载PDF
导出
摘要 目的:研究干扰素-γ对宫颈癌细胞免疫分子表达的影响,探讨其在宫颈癌治疗中的免疫作用机制。方法:采用流式细胞术检测官颈癌细胞HLA-DR、CD80和CD40的表达。结果:干扰素-γ可增加宫颈癌细胞表面HLA DR和CD40的表达,对宫颈癌细胞表面CD80的表达无明显影响。结论:干扰素-γ抗肿瘤效应可能与上调宫颈癌细胞表面CD40和HLA DR分子表达有关。 Objective :To study the effect of interferon-γ on expression of immune molecules on the cervical tumor cell and to investigate its mechanism in cervical cancer therapy.Methods:The expression of HLA DR,CD40 and CD80 on the tumor cell was detected respectively by flow cytometry.Results:Interferun-γincreased the expression of HLA DR and CD40 on the tumor cell,but not CD80.Conclusion: Anfitumor effect of Interferon-γis associated with the enhanced expression of HLA-DR and CD40 on the tumor cell surface.
作者 周晨慧
出处 《现代医药卫生》 2007年第1期8-9,共2页 Journal of Modern Medicine & Health
关键词 宫颈癌 主要组织相容性复合体 Γ干扰素 Cervical cancer, Major histocompatibility complex Interferon-γ
  • 相关文献

参考文献6

  • 1Gey A,Kumari P,.Sambandam A.Identification and characterisation of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFNgamma) and Type 2(IL-4) cytokine mRNA expression[J].Eur J Cancer,2003,39(5):.595.
  • 2Elsherif AM,Seth R,Tighe PJ,et al.Quantitative analysis of IL-IO and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precance[J].J Pathol, 2001,195(2):179.
  • 3Guckel B,Stumm S,Rentzsch C,et al.A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A^*O2-matched situations in vitro as well as in vivo[J]. Cancer Immunol Immunother,2005,54(2): 129.
  • 4Hill SC,Youde SJ,Man S,et al.Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis[J].J Immunol,2005,174(1):41.
  • 5Wada A,Tada Y,Shimozato O,et al.Expression of CD40 lisand in CD40-positive murine tumors activates transcription of the interleukin-23 subunit genes and produces antitumor responses[J].Anticancer Res,2004,24(5A):2713.
  • 6Dissanayake SK,Thompson JA.Bosch JJ,et al.Activation of tumor-specific CD4^+ lymphocyte by major histocompatibility complex class Ⅱ tumor cell vaccines:a novel cell-based immunotherapy[J].Cancer Res,2004,64:1867.

同被引文献31

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部